| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | defense response to virus | 8.16e-06 | 342 | 62 | 8 | GO:0051607 | |
| GeneOntologyBiologicalProcess | response to virus | 3.89e-05 | 425 | 62 | 8 | GO:0009615 | |
| GeneOntologyCellularComponent | symbiont cell surface | 2.47e-04 | 8 | 63 | 2 | GO:0106139 | |
| GeneOntologyCellularComponent | other organism part | 3.17e-04 | 9 | 63 | 2 | GO:0044217 | |
| Domain | LRR_6 | 2.18e-08 | 55 | 60 | 6 | PF13516 | |
| Domain | DAPIN | 6.74e-07 | 22 | 60 | 4 | PS50824 | |
| Domain | PYRIN | 6.74e-07 | 22 | 60 | 4 | PF02758 | |
| Domain | DAPIN | 6.74e-07 | 22 | 60 | 4 | IPR004020 | |
| Domain | PYRIN | 6.74e-07 | 22 | 60 | 4 | SM01289 | |
| Domain | - | 8.01e-07 | 321 | 60 | 9 | 3.80.10.10 | |
| Domain | NACHT | 8.14e-07 | 23 | 60 | 4 | PS50837 | |
| Domain | NACHT_NTPase | 8.14e-07 | 23 | 60 | 4 | IPR007111 | |
| Domain | L_dom-like | 9.58e-07 | 328 | 60 | 9 | IPR032675 | |
| Domain | Leu-rich_rpt | 2.36e-06 | 271 | 60 | 8 | IPR001611 | |
| Domain | - | 1.21e-05 | 93 | 60 | 5 | 1.10.533.10 | |
| Domain | DEATH-like_dom | 1.64e-05 | 99 | 60 | 5 | IPR011029 | |
| Domain | BBOX | 7.12e-05 | 69 | 60 | 4 | SM00336 | |
| Domain | zf-B_box | 8.41e-05 | 72 | 60 | 4 | PF00643 | |
| Domain | Anaphylatoxin_comp_syst | 1.01e-04 | 5 | 60 | 2 | IPR018081 | |
| Domain | Anaphylatoxn_comp_syst_dom | 1.01e-04 | 5 | 60 | 2 | IPR001840 | |
| Domain | ZF_BBOX | 1.27e-04 | 80 | 60 | 4 | PS50119 | |
| Domain | Znf_B-box | 1.33e-04 | 81 | 60 | 4 | IPR000315 | |
| Domain | ANATO | 2.11e-04 | 7 | 60 | 2 | SM00104 | |
| Domain | ANATO | 2.11e-04 | 7 | 60 | 2 | PF01821 | |
| Domain | ANAPHYLATOXIN_2 | 2.11e-04 | 7 | 60 | 2 | PS01178 | |
| Domain | ANAPHYLATOXIN_1 | 2.11e-04 | 7 | 60 | 2 | PS01177 | |
| Domain | Anaphylatoxin/fibulin | 2.11e-04 | 7 | 60 | 2 | IPR000020 | |
| Domain | Thiol-ester_cl | 2.81e-04 | 8 | 60 | 2 | PF10569 | |
| Domain | MacrogloblnA2_thiol-ester-bond | 2.81e-04 | 8 | 60 | 2 | IPR019565 | |
| Domain | MacrogloblnA2_CS | 2.81e-04 | 8 | 60 | 2 | IPR019742 | |
| Domain | ZF_RING_1 | 3.36e-04 | 291 | 60 | 6 | PS00518 | |
| Domain | ZF_RING_2 | 3.81e-04 | 298 | 60 | 6 | PS50089 | |
| Domain | RING | 4.31e-04 | 305 | 60 | 6 | SM00184 | |
| Domain | A2M_N | 4.49e-04 | 10 | 60 | 2 | PF01835 | |
| Domain | A2M_N | 4.49e-04 | 10 | 60 | 2 | IPR002890 | |
| Domain | A-macroglobulin_rcpt-bd | 4.49e-04 | 10 | 60 | 2 | IPR009048 | |
| Domain | ALPHA_2_MACROGLOBULIN | 4.49e-04 | 10 | 60 | 2 | PS00477 | |
| Domain | A2M | 4.49e-04 | 10 | 60 | 2 | PF00207 | |
| Domain | A2M_N_2 | 4.49e-04 | 10 | 60 | 2 | IPR011625 | |
| Domain | A2M_comp | 4.49e-04 | 10 | 60 | 2 | IPR011626 | |
| Domain | A2M_N_2 | 4.49e-04 | 10 | 60 | 2 | PF07703 | |
| Domain | A2M_recep | 4.49e-04 | 10 | 60 | 2 | PF07677 | |
| Domain | A2M_comp | 4.49e-04 | 10 | 60 | 2 | PF07678 | |
| Domain | Macroglobln_a2 | 4.49e-04 | 10 | 60 | 2 | IPR001599 | |
| Domain | - | 5.70e-04 | 449 | 60 | 7 | 3.30.40.10 | |
| Domain | Znf_RING | 6.12e-04 | 326 | 60 | 6 | IPR001841 | |
| Domain | Znf_RING/FYVE/PHD | 6.49e-04 | 459 | 60 | 7 | IPR013083 | |
| Domain | LRR_1 | 6.85e-04 | 219 | 60 | 5 | PF00560 | |
| Domain | zf-C3HC4 | 7.43e-04 | 223 | 60 | 5 | PF00097 | |
| Domain | Interferon_alpha/beta/delta | 1.34e-03 | 17 | 60 | 2 | IPR000471 | |
| Domain | C345C | 1.34e-03 | 17 | 60 | 2 | SM00643 | |
| Domain | Interferon | 1.34e-03 | 17 | 60 | 2 | PF00143 | |
| Domain | IFabd | 1.34e-03 | 17 | 60 | 2 | SM00076 | |
| Domain | INTERFERON_A_B_D | 1.34e-03 | 17 | 60 | 2 | PS00252 | |
| Domain | Butyrophylin | 1.48e-03 | 70 | 60 | 3 | IPR003879 | |
| Domain | Terpenoid_cyclase/PrenylTrfase | 1.50e-03 | 18 | 60 | 2 | IPR008930 | |
| Domain | - | 1.54e-03 | 71 | 60 | 3 | 4.10.45.10 | |
| Domain | NTR | 1.68e-03 | 19 | 60 | 2 | PF01759 | |
| Domain | Leu-rich_rpt_Cys-con_subtyp | 1.68e-03 | 19 | 60 | 2 | IPR006553 | |
| Domain | Netrin_module_non-TIMP | 1.68e-03 | 19 | 60 | 2 | IPR018933 | |
| Domain | LRR_CC | 1.68e-03 | 19 | 60 | 2 | SM00367 | |
| Domain | Znf_RING_CS | 1.86e-03 | 163 | 60 | 4 | IPR017907 | |
| Domain | Claudin_CS | 2.25e-03 | 22 | 60 | 2 | IPR017974 | |
| Domain | CLAUDIN | 2.25e-03 | 22 | 60 | 2 | PS01346 | |
| Domain | Pentatricopeptide_repeat | 2.46e-03 | 23 | 60 | 2 | IPR002885 | |
| Domain | NTR | 2.46e-03 | 23 | 60 | 2 | PS50189 | |
| Domain | Netrin_domain | 2.46e-03 | 23 | 60 | 2 | IPR001134 | |
| Domain | TIMP-like_OB-fold | 3.14e-03 | 26 | 60 | 2 | IPR008993 | |
| Domain | SPRY | 3.43e-03 | 94 | 60 | 3 | PF00622 | |
| Domain | SPRY_dom | 3.43e-03 | 94 | 60 | 3 | IPR003877 | |
| Domain | B30.2/SPRY | 3.54e-03 | 95 | 60 | 3 | IPR001870 | |
| Domain | B302_SPRY | 3.54e-03 | 95 | 60 | 3 | PS50188 | |
| Domain | Claudin | 3.64e-03 | 28 | 60 | 2 | IPR006187 | |
| Domain | ConA-like_dom | 5.37e-03 | 219 | 60 | 4 | IPR013320 | |
| Domain | 7TM_GPCR_Srsx | 5.60e-03 | 112 | 60 | 3 | SM01381 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 2.26e-04 | 7 | 47 | 2 | MM14685 | |
| Pathway | REACTOME_INTERFERON_SIGNALING | 2.75e-04 | 273 | 47 | 6 | M983 | |
| Pathway | REACTOME_ACTIVATION_OF_C3_AND_C5 | 3.01e-04 | 8 | 47 | 2 | M27031 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CLASSICAL_PATHWAY_OF_COMPLEMENT_CASCADE_C4_C2_TO_C3_CONVERTASE_FORMATION | 3.01e-04 | 8 | 47 | 2 | M47872 | |
| Pubmed | 9.04e-09 | 14 | 62 | 4 | 20403135 | ||
| Pubmed | 9.04e-09 | 14 | 62 | 4 | 12563287 | ||
| Pubmed | 5.35e-08 | 21 | 62 | 4 | 15937080 | ||
| Pubmed | Epistatic suppression of systemic lupus erythematosus: fine mapping of Sles1 to less than 1 mb. | 1.94e-06 | 14 | 62 | 3 | 16002707 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 22737222 | ||
| Pubmed | Deficiency of C4 from donor or recipient mouse fails to prevent renal allograft rejection. | 3.13e-06 | 2 | 62 | 2 | 16565498 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 15998580 | ||
| Pubmed | Structural polymorphism of murine C4 and its linkage to H-2. | 3.13e-06 | 2 | 62 | 2 | 7373044 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 19062096 | ||
| Pubmed | The chemical structure of the C4d fragment of the human complement component C4. | 3.13e-06 | 2 | 62 | 2 | 3696167 | |
| Pubmed | Restriction fragment length polymorphism of the murine C4 and Slp genes: two C4 groups. | 3.13e-06 | 2 | 62 | 2 | 1357031 | |
| Pubmed | Structural comparison of human C4A3 and C4B1 after proteolytic activation by C1s. | 3.13e-06 | 2 | 62 | 2 | 16098595 | |
| Pubmed | Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice. | 3.13e-06 | 2 | 62 | 2 | 19933335 | |
| Pubmed | Structural basis for the C4d.1/C4d.2 serologic allotypes of murine complement component C4. | 3.13e-06 | 2 | 62 | 2 | 2459207 | |
| Pubmed | Antigen-induced B cell apoptosis is independent of complement C4. | 3.13e-06 | 2 | 62 | 2 | 17645767 | |
| Pubmed | Increased frequency of C4B*Q0 alleles in patients with Henoch-Schönlein purpura. | 3.13e-06 | 2 | 62 | 2 | 15787745 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 12207352 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 30026462 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 6559257 | ||
| Pubmed | Complement C4A and C4B Gene Copy Number Study in Alzheimer's Disease Patients. | 3.13e-06 | 2 | 62 | 2 | 27758680 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 22387014 | ||
| Pubmed | Complement C4 Is Reduced in iPSC-Derived Astrocytes of Autism Spectrum Disorder Subjects. | 3.13e-06 | 2 | 62 | 2 | 34299197 | |
| Pubmed | Assessment of complement C4 gene copy number using the paralog ratio test. | 3.13e-06 | 2 | 62 | 2 | 20506482 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 12480675 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 26800705 | ||
| Pubmed | Complement C4 maintains peripheral B-cell tolerance in a myeloid cell dependent manner. | 3.13e-06 | 2 | 62 | 2 | 23749435 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 23918728 | ||
| Pubmed | Murine complement C4 is not required for experimental autoimmune encephalomyelitis. | 3.13e-06 | 2 | 62 | 2 | 15390104 | |
| Pubmed | Molecular genetics of androgen-dependent and -independent expression of mouse sex-limited protein. | 3.13e-06 | 2 | 62 | 2 | 3037333 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 11726230 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 4216347 | ||
| Pubmed | Importance of the alpha 3-fragment of complement C4 for the binding with C4b-binding protein. | 3.13e-06 | 2 | 62 | 2 | 1699796 | |
| Pubmed | Sequence determination of the thiolester site of the fourth component of human complement. | 3.13e-06 | 2 | 62 | 2 | 6950384 | |
| Pubmed | Molecular cloning and characterization of complementary and genomic DNA clones for mouse C4 and Slp. | 3.13e-06 | 2 | 62 | 2 | 2997024 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 8660986 | ||
| Pubmed | Constitutive expression of Slp genes in mouse strain B10.WR directed by C4 regulatory sequences. | 3.13e-06 | 2 | 62 | 2 | 3624865 | |
| Pubmed | Tissue-specific RNA processing for the complement C4 gene transcript in the H-2k mouse strain. | 3.13e-06 | 2 | 62 | 2 | 8428773 | |
| Pubmed | The PYRIN domain: a novel motif found in apoptosis and inflammation proteins. | 3.13e-06 | 2 | 62 | 2 | 11270363 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 21857912 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 24638111 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 6208559 | ||
| Pubmed | The role of the histocompatibility-2-linked Ss-Slp region in the control of mouse complement. | 3.13e-06 | 2 | 62 | 2 | 4514997 | |
| Pubmed | Transcriptional repression of C4 complement by hepatitis C virus proteins. | 3.13e-06 | 2 | 62 | 2 | 21345967 | |
| Pubmed | The inheritance of susceptibility to the Gross leukemia virus in mice. | 3.13e-06 | 2 | 62 | 2 | 5919331 | |
| Pubmed | An ancient provirus has imposed androgen regulation on the adjacent mouse sex-limited protein gene. | 3.13e-06 | 2 | 62 | 2 | 3167981 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 7545960 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 30041577 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 2572548 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 2302180 | ||
| Pubmed | Complete cDNA sequence of the fourth component of murine complement. | 3.13e-06 | 2 | 62 | 2 | 3862104 | |
| Pubmed | The BS variant of C4 protects against age-related loss of white matter microstructural integrity. | 3.13e-06 | 2 | 62 | 2 | 34358307 | |
| Pubmed | Acute renal allograft rejection: diagnostic significance of focal peritubular capillary C4d. | 3.13e-06 | 2 | 62 | 2 | 18360261 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 22151770 | ||
| Pubmed | C4d-positive chronic rejection: a frequent entity with a poor outcome. | 3.13e-06 | 2 | 62 | 2 | 18091514 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 29080553 | ||
| Pubmed | Schizophrenia risk from complex variation of complement component 4. | 3.13e-06 | 2 | 62 | 2 | 26814963 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 6589636 | ||
| Pubmed | C4 Deficiency is a predisposing factor for Streptococcus pneumoniae-induced autoantibody production. | 3.13e-06 | 2 | 62 | 2 | 25339671 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 17728371 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 6149580 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 6149581 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 12115608 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 3542363 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 2387317 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 8132550 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 2395880 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 26814708 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 6192448 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 6167582 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 16908004 | ||
| Pubmed | Slp is an essential component of an EDTA-resistant activation pathway of mouse complement. | 3.13e-06 | 2 | 62 | 2 | 1438267 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 7365238 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 19150565 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 7391573 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 17506029 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 17971360 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 23715124 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 3464002 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 2993295 | ||
| Pubmed | Clinical features of patients with homozygous complement C4A or C4B deficiency. | 3.13e-06 | 2 | 62 | 2 | 29928053 | |
| Pubmed | Analysis of C4 and the C4 binding protein in the MRL/lpr mouse. | 3.13e-06 | 2 | 62 | 2 | 17971229 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 6881182 | ||
| Pubmed | Mutations in NLRP2 and NLRP5 cause female infertility characterised by early embryonic arrest. | 3.13e-06 | 2 | 62 | 2 | 30877238 | |
| Pubmed | Identification of the site of sulfation of the fourth component of human complement. | 3.13e-06 | 2 | 62 | 2 | 3944109 | |
| Pubmed | Partial C4 deficiency in juvenile idiopathic arthritis patients. | 3.13e-06 | 2 | 62 | 2 | 17921792 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 25412268 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 21880985 | ||
| Pubmed | Amino acid sequence around the thiol and reactive acyl groups of human complement component C4. | 3.13e-06 | 2 | 62 | 2 | 6978711 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 35898513 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 33353966 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 3008092 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 28873507 | ||
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 6609966 | ||
| Pubmed | Heterogeneity and linkage of equine C4 and steroid 21-hydroxylase genes. | 3.13e-06 | 2 | 62 | 2 | 2900855 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 276882 | ||
| Pubmed | Amino acid sequence of a polymorphic segment from fragment C4d of human complement component C4. | 3.13e-06 | 2 | 62 | 2 | 6832377 | |
| Pubmed | TRIM34 restricts HIV-1 and SIV capsids in a TRIM5α-dependent manner. | 3.13e-06 | 2 | 62 | 2 | 32282853 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 3794341 | ||
| Pubmed | Complement and c4 null alleles in severe chronic adult periodontitis. | 3.13e-06 | 2 | 62 | 2 | 17257223 | |
| Pubmed | 3.13e-06 | 2 | 62 | 2 | 2272665 | ||
| Cytoband | 9p22 | 5.54e-06 | 25 | 63 | 3 | 9p22 | |
| Cytoband | 3p22.3 | 8.40e-04 | 31 | 63 | 2 | 3p22.3 | |
| GeneFamily | Pyrin domain containing|Pyrin and HIN domain family | 7.95e-07 | 25 | 53 | 4 | 994 | |
| GeneFamily | NLR family | 7.95e-07 | 25 | 53 | 4 | 666 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 1.72e-04 | 95 | 53 | 4 | 59 | |
| GeneFamily | C3 and PZP like, alpha-2-macroglobulin domain containing | 3.00e-04 | 9 | 53 | 2 | 1234 | |
| GeneFamily | Ring finger proteins | 1.24e-03 | 275 | 53 | 5 | 58 | |
| GeneFamily | F-box and leucine rich repeat proteins | 1.71e-03 | 21 | 53 | 2 | 558 | |
| GeneFamily | Claudins | 2.05e-03 | 23 | 53 | 2 | 488 | |
| GeneFamily | Interferons | 3.95e-03 | 32 | 53 | 2 | 598 | |
| GeneFamily | Complement system|Sushi domain containing | 4.98e-03 | 36 | 53 | 2 | 492 | |
| GeneFamily | Glycosyltransferase family 6|Blood group antigens | 5.26e-03 | 37 | 53 | 2 | 454 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.80e-05 | 123 | 63 | 4 | a45d6907c041ad3f3218cd46dccfc25d4bd961cb | |
| ToppCell | facs-Liver-Hepatocytes|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.06e-05 | 156 | 63 | 4 | e2cda3ad4e5f44a80133864c5a38b766afb952ce | |
| ToppCell | droplet-Marrow-BM-1m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-05 | 168 | 63 | 4 | 2e88d9cb7c80a4656fab290db8b45a5a0599d769 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 172 | 63 | 4 | 356a66cd9303470e427005cc67fdd22a2c4bf971 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 172 | 63 | 4 | 46fadeee483fdf8402df92ec98575a09c6c15b16 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 172 | 63 | 4 | 438d2e7f1897668a14d85ca70722e5d0102606dc | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.05e-04 | 173 | 63 | 4 | d1e47c87bd4750801f3531f66a56c5dccb4ea64c | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mast-Mast-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.05e-04 | 173 | 63 | 4 | 3a39c7f290a9914fcf747e6bc6f13a509413b33c | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.08e-04 | 174 | 63 | 4 | c529f3674b784f872f4387ffdeb46aecb619976b | |
| ToppCell | 10x3'2.3-week_14-16-Myeloid_macrophage-stroma-monocytoid_macrophage|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.18e-04 | 178 | 63 | 4 | e44b0aa82890ae84fc4d1343f1c65ae2fda69a11 | |
| ToppCell | 3'-Airway_Nasal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_acinar_cell-SMG_duct-SMG_duct_L.0.6.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-04 | 179 | 63 | 4 | ec331b1132f965581f851a3b29e62873c4140e6c | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Mucous-Mucous|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.20e-04 | 179 | 63 | 4 | dc4d1b3f63df2c657fea51da011488ee724ee1bf | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Mucous|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.20e-04 | 179 | 63 | 4 | 9caa7903950c806921b1036103ad0d332a441253 | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_mucus_secreting_cell-SMG_mucous-SMG_mucous_L.0.6.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.23e-04 | 180 | 63 | 4 | 8af51245ac1269f318268f574cfaddb0b8c80a53 | |
| ToppCell | normal_Lung-Myeloid_cells-CD207+CD1a+_LCs|normal_Lung / Location, Cell class and cell subclass | 1.25e-04 | 181 | 63 | 4 | b55dbcfae8c92d322071906831489830a22239b9 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 182 | 63 | 4 | 770ce9f3f4538d0181a0181543841bc964c68274 | |
| ToppCell | IPF-Myeloid-DC_Langerhans|World / Disease state, Lineage and Cell class | 1.28e-04 | 182 | 63 | 4 | 0e8cfbd8ea196f27a227dbb4d2eb93bc48d27922 | |
| ToppCell | normal_Lung-Myeloid_cells-CD207+CD1a+_LCs|Myeloid_cells / Location, Cell class and cell subclass | 1.28e-04 | 182 | 63 | 4 | 8dd79fef8f8463ad3194f9cc07c6cacf2c886304 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 182 | 63 | 4 | 77ab860e2add49dad0c1ffbfc64278ad499dfbd5 | |
| ToppCell | facs-Liver-Hepatocytes-24m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-04 | 182 | 63 | 4 | 4921c7d5687cc79f896b39753bb621d7e3d2972f | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.31e-04 | 183 | 63 | 4 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 1.34e-04 | 184 | 63 | 4 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | IPF-Myeloid-DC_Langerhans|IPF / Disease state, Lineage and Cell class | 1.36e-04 | 185 | 63 | 4 | f8ee3cb2aa9ec70f9ce8797be2b155da27ef6464 | |
| ToppCell | IPF-Myeloid-DC_Langerhans|Myeloid / Disease state, Lineage and Cell class | 1.36e-04 | 185 | 63 | 4 | ced17f69486591c3cbbdc852a3e82c3f3a4a30d7 | |
| ToppCell | systemic_lupus_erythematosus-flare-Hematopoietic-progenitor_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.39e-04 | 186 | 63 | 4 | ffd4510b4435d9bf94c2ef14c629f73ab78c5d93 | |
| ToppCell | TCGA-Kidney-Primary_Tumor-Renal_Cell_Carcinoma-Kidney_Clear_Cell_Renal_Carcinoma|TCGA-Kidney / Sample_Type by Project: Shred V9 | 1.45e-04 | 188 | 63 | 4 | e711c7a46d7cfa030ca2982eacc1dae5af5788dd | |
| ToppCell | 343B-Lymphocytic-ILC-ILC-1|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.45e-04 | 188 | 63 | 4 | 8f6b45ad82bde65e044d17f0edbc3db90d457915 | |
| ToppCell | systemic_lupus_erythematosus-flare-Hematopoietic-progenitor_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.45e-04 | 188 | 63 | 4 | c613c6c7b6de8ed514253c9f9b8622c56fcc1452 | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_mucus_secreting_cell-SMG_mucous|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.48e-04 | 189 | 63 | 4 | 8777a341dd4f02ac5ee45c6c489ce74f4c87ce15 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 189 | 63 | 4 | 1db5dd1ef2a65251af2d5696622d1dd9c4ae2b55 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 189 | 63 | 4 | bfb1c183a8a2752a2368b74150e66181c6a9da48 | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_mucus_secreting_cell-SMG_mucous-SMG_mucous_L.0.6.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.48e-04 | 189 | 63 | 4 | 86d751cca35c42067157e218567daf9ab9d5f907 | |
| ToppCell | 3'-Broncho-tracheal_SMG-Epithelial-Epithelial_transtional-secretory-SMG_mucus_secreting_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.48e-04 | 189 | 63 | 4 | ccc5436ef22016559bfdaca12b9ab5ce8d5944b1 | |
| ToppCell | 18-Airway-Epithelial-Submucosal_gland|Airway / Age, Tissue, Lineage and Cell class | 1.48e-04 | 189 | 63 | 4 | c1ea2dc44cf5340378e56e0ffc2e6f64e6c95a58 | |
| ToppCell | facs-Thymus-Epithelium-3m-Mesenchymal-fibroblast|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 189 | 63 | 4 | 14833feea8f80744a06ece73f813eaeff8c4dd61 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.54e-04 | 191 | 63 | 4 | cadb7a9de16f4bb21606de0e25cddd2d748c7f0b | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Endothelial-kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 192 | 63 | 4 | c0498baa2556e1597c00df2e75efadeb14bd34ef | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.57e-04 | 192 | 63 | 4 | 0b954a4e5857dac45d97c491af9b27cb2d1bd339 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Endothelial-Pecam____Kidney_cortex_artery_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 192 | 63 | 4 | cb906b10cad76e978c5c0b966215368ebef30e51 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Endothelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-04 | 193 | 63 | 4 | 3a5090f81f35026f435f4a250d1e77601a53af15 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-04 | 193 | 63 | 4 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | droplet-Bladder-BLADDER-1m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-04 | 193 | 63 | 4 | 13731b7fc1e3bec0cebc44bad7e2ecea358bb76a | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Lymphoid-B_cell-B_cell-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.64e-04 | 194 | 63 | 4 | 9a99abc65e7509e7ae8fb392f5ee4b2a83128072 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.67e-04 | 195 | 63 | 4 | 7cdee2ae90edf15e4cbcf70797b8caf1f037b0ef | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 1.67e-04 | 195 | 63 | 4 | b61b8c931bd0ca3678486653ae1d7e9915c696c7 | |
| ToppCell | Mesenchymal_cells-Fibro/Chondro_p.|World / Lineage and Cell class | 1.70e-04 | 196 | 63 | 4 | ddc168849e0e97005a111be004463bb72d433853 | |
| ToppCell | MS-IIF-Others-HSPC|IIF / Disease, condition lineage and cell class | 1.80e-04 | 199 | 63 | 4 | 3384db80f6024bcabe2625f24d5f4e0d3d8caa7e | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Airway-Club|LPS_only / Treatment groups by lineage, cell group, cell type | 1.80e-04 | 199 | 63 | 4 | 165ac94b2d56072ad43358b5127d77555221e2d8 | |
| ToppCell | (02)_MMP9/10+|World / shred by cell type by condition | 1.80e-04 | 199 | 63 | 4 | 3f78eddeaa67d3b767aa38de765632166b09a4f0 | |
| Computational | Neighborhood of BCL2 | 1.37e-04 | 223 | 39 | 6 | MORF_BCL2 | |
| Computational | Neighborhood of TNFRSF25 | 3.56e-04 | 266 | 39 | 6 | MORF_TNFRSF25 | |
| Drug | WAY-100635 | 9.63e-06 | 49 | 62 | 4 | CID000005684 | |
| Drug | GR 55562 | 1.52e-05 | 18 | 62 | 3 | CID000128017 | |
| Drug | 5-CT | 1.53e-05 | 55 | 62 | 4 | CID000001809 | |
| Drug | SCH 23390 | 1.62e-05 | 116 | 62 | 5 | CID000005018 | |
| Drug | cyanopindolol | 1.77e-05 | 57 | 62 | 4 | CID000155346 | |
| Drug | 2-aminothiophenol | 2.18e-05 | 3 | 62 | 2 | ctd:C005464 | |
| Drug | ipsapirone | 2.32e-05 | 61 | 62 | 4 | CID000056971 | |
| Disease | Mood Disorders | 2.20e-05 | 168 | 59 | 5 | C0525045 | |
| Disease | Ocular Headache | 3.92e-05 | 5 | 59 | 2 | C0028838 | |
| Disease | Hemicrania | 3.92e-05 | 5 | 59 | 2 | C0877781 | |
| Disease | Headache | 3.92e-05 | 5 | 59 | 2 | C0018681 | |
| Disease | Bilateral Headache | 3.92e-05 | 5 | 59 | 2 | C0423623 | |
| Disease | Throbbing Headache | 3.92e-05 | 5 | 59 | 2 | C0423618 | |
| Disease | Generalized Headache | 3.92e-05 | 5 | 59 | 2 | C0474366 | |
| Disease | Sharp Headache | 3.92e-05 | 5 | 59 | 2 | C0751190 | |
| Disease | Vertex Headache | 3.92e-05 | 5 | 59 | 2 | C0751192 | |
| Disease | Orthostatic Headache | 3.92e-05 | 5 | 59 | 2 | C0751186 | |
| Disease | Periorbital Headache | 3.92e-05 | 5 | 59 | 2 | C0751187 | |
| Disease | Retro-Ocular Headache | 3.92e-05 | 5 | 59 | 2 | C0751189 | |
| Disease | Schizophrenia | 3.58e-04 | 883 | 59 | 8 | C0036341 | |
| Disease | Antibody Deficiency Syndrome | 5.24e-04 | 17 | 59 | 2 | C0003257 | |
| Disease | Headache, HbA1c measurement | 8.05e-04 | 21 | 59 | 2 | EFO_0004541, HP_0002315 | |
| Disease | vitiligo (is_implicated_in) | 8.05e-04 | 21 | 59 | 2 | DOID:12306 (is_implicated_in) | |
| Disease | Immunologic Deficiency Syndromes | 9.68e-04 | 23 | 59 | 2 | C0021051 | |
| Disease | Weight decreased | 9.68e-04 | 23 | 59 | 2 | C1262477 | |
| Disease | Drug-Induced Stevens Johnson Syndrome | 1.54e-03 | 29 | 59 | 2 | C1274933 | |
| Disease | Toxic Epidermal Necrolysis | 1.54e-03 | 29 | 59 | 2 | C0014518 | |
| Disease | Mycoplasma-Induced Stevens-Johnson Syndrome | 1.54e-03 | 29 | 59 | 2 | C3658301 | |
| Disease | Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum | 1.54e-03 | 29 | 59 | 2 | C3658302 | |
| Disease | Stevens-Johnson Syndrome | 1.65e-03 | 30 | 59 | 2 | C0038325 | |
| Disease | Complement deficiency disease | 1.99e-03 | 33 | 59 | 2 | C0272242 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TATSILALCGVTCLC | 16 | Q7L8C5 | |
| CLASSNEALTEGLTC | 141 | P40313 | |
| LLLGGCLLNCAACSS | 176 | A6NM45 | |
| VSSLRSPLCLNCGSC | 161 | Q6ZUL3 | |
| SRLLATLCSAEVCQC | 1576 | P0C0L5 | |
| CCEGRELLLCSNTSC | 481 | Q9UBC3 | |
| CCTCSILHLSAIALD | 106 | P30939 | |
| ISCDCDLLGSLAFCL | 181 | Q9Y672 | |
| CIGRALSSSSIDCLC | 461 | Q9H9E3 | |
| VLCCTASILSLCAIS | 126 | P35368 | |
| LALSILADCCTEGAC | 131 | Q96C12 | |
| CLCCASVAAALASDS | 36 | Q8TE60 | |
| ACKNSICLDLSTNCL | 836 | Q6ZS30 | |
| LQALCLSGCSNLTDA | 236 | Q9UKC9 | |
| LVVLSCKSSCSLGCN | 11 | P01570 | |
| ISCCAMLECLSLSDN | 391 | A4D1F6 | |
| LCSSGRCVAEALLCN | 2911 | Q07954 | |
| LVVLSCKSSCSLGCD | 11 | P01562 | |
| LVSCGLTSDCCQDLA | 901 | Q9C000 | |
| LLCAQLLDTCLCKGS | 301 | Q8N819 | |
| CLCSNLGVTSLACDD | 186 | Q8NGI3 | |
| CEDLCSALSCNQSLV | 971 | Q9NX02 | |
| LKACGLTSDCCEALS | 1101 | P59047 | |
| LTSDCCEALSLALSC | 1106 | P59047 | |
| TSKLSDANCCLDAIC | 261 | Q9HC97 | |
| QACATCLILACSTAA | 546 | O75694 | |
| CLCSNLGVTSLSCDD | 186 | Q8NGI1 | |
| LCCLLTGCTTFEEAL | 421 | Q9BZ23 | |
| LTFGCCEALCLLSTA | 1021 | P42858 | |
| LSLDLQAGLDCCCLA | 2271 | P42858 | |
| NLSSLVSCLCVNLCS | 1061 | Q86XA9 | |
| AASLCLLGGALLCCS | 171 | O95832 | |
| TRLEASLCSCSDDCL | 106 | O14638 | |
| LCADTCSLGCSALSA | 2741 | Q9Y6R7 | |
| ELCADTCSLGCSALS | 3941 | Q9Y6R7 | |
| QSGAAFSCSCVVLLC | 631 | O60266 | |
| LLVLSCKSSCSVGCD | 11 | P01563 | |
| EILLSSCSLCRACDS | 1151 | O75064 | |
| VILCTCSCAASASLK | 2336 | Q9BYK8 | |
| SRLLATLCSAEVCQC | 1576 | P0C0L4 | |
| KSLCRTGSCSELDAC | 1691 | Q9H1H9 | |
| LSLDCGHSLCRACIT | 26 | Q9BYJ4 | |
| AALPAALSCLSCLAS | 136 | Q96LD4 | |
| TNCGRLQSCSECILA | 511 | O95754 | |
| LCCSCALLDSSHSEL | 211 | P29590 | |
| SLCASGCSNITDAIL | 251 | Q96IG2 | |
| LACCLLGLLALTSAC | 6 | P01178 | |
| ILPALSCCSNLTTFC | 371 | A3QJZ6 | |
| TCGGLQALCTLLYSC | 76 | Q9BY78 | |
| QALCTLLYSCCSGLE | 81 | Q9BY78 | |
| HRLACCSLDGSISLC | 186 | Q9H1Z4 | |
| SLCLCLCLAAALGSA | 16 | Q8IXL7 | |
| QCSTNPLTGSTLCLC | 406 | Q99466 | |
| TSAATLSCLGECLNL | 281 | Q9BXB5 | |
| VSLNDCLACSGCITS | 66 | Q9H6Q4 | |
| LSLDCGHSFCQACLT | 26 | Q9C035 | |
| LSCSAGALITCLASL | 1111 | Q8IWN7 | |
| CSLVSGAASLDASCL | 96 | P43007 | |
| CRELGFSSNLLCSSC | 41 | O60613 | |
| STAQCLLCGLCYTSA | 1151 | Q92610 | |
| ACCLLTSLCDTVGAL | 66 | Q2T9K0 | |
| SLSSCLCVSQELIFC | 296 | O43379 | |
| LAGCLGALCENTCLL | 136 | Q9H1Z9 | |
| TLCLVCGSLLCSQSY | 1631 | Q8IWV8 | |
| RGACAALSSCLLLAC | 6 | A0A286YF58 | |
| GACSLLSCASCLCGS | 6 | Q96SA4 | |
| LLGLCVALSCSSAAA | 6 | Q96QR1 | |
| SGSLACCATDLLALC | 286 | P23378 | |
| CVCQNLSESLSTLCA | 21 | Q6PJG9 | |
| CGLTSLCCQDLSSAL | 996 | Q86W24 |